450 related articles for article (PubMed ID: 34641123)
1. Application of Non-Viral Vectors in Drug Delivery and Gene Therapy.
Ren S; Wang M; Wang C; Wang Y; Sun C; Zeng Z; Cui H; Zhao X
Polymers (Basel); 2021 Sep; 13(19):. PubMed ID: 34641123
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in nanotechnology approaches for non-viral gene therapy.
Jiang Y; Fan M; Yang Z; Liu X; Xu Z; Liu S; Feng G; Tang S; Li Z; Zhang Y; Chen S; Yang C; Law WC; Dong B; Xu G; Yong KT
Biomater Sci; 2022 Dec; 10(24):6862-6892. PubMed ID: 36222758
[TBL] [Abstract][Full Text] [Related]
3. Nanotechnology-based non-viral vectors for gene delivery in cardiovascular diseases.
Jiao L; Sun Z; Sun Z; Liu J; Deng G; Wang X
Front Bioeng Biotechnol; 2024; 12():1349077. PubMed ID: 38303912
[TBL] [Abstract][Full Text] [Related]
4. Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking.
Khalil IA; Kogure K; Futaki S; Harashima H
Int J Pharm; 2008 Apr; 354(1-2):39-48. PubMed ID: 18242018
[TBL] [Abstract][Full Text] [Related]
5. Delivery of CRISPR/Cas9 for therapeutic genome editing.
Xu X; Wan T; Xin H; Li D; Pan H; Wu J; Ping Y
J Gene Med; 2019 Jul; 21(7):e3107. PubMed ID: 31237055
[TBL] [Abstract][Full Text] [Related]
6. Synthetic nanocarriers for intracellular protein delivery.
Du J; Jin J; Yan M; Lu Y
Curr Drug Metab; 2012 Jan; 13(1):82-92. PubMed ID: 22292811
[TBL] [Abstract][Full Text] [Related]
7. Viral vector mimicking and nucleus targeted nanoparticles based on dexamethasone polyethylenimine nanoliposomes: Preparation and evaluation of transfection efficiency.
Malaekeh-Nikouei B; Gholami L; Asghari F; Askarian S; Barzegar S; Rezaee M; Kazemi Oskuee R
Colloids Surf B Biointerfaces; 2018 May; 165():252-261. PubMed ID: 29494955
[TBL] [Abstract][Full Text] [Related]
8. Building a Better Silver Bullet: Current Status and Perspectives of Non-Viral Vectors for mRNA Vaccines.
Gu J; Xu Z; Liu Q; Tang S; Zhang W; Xie S; Chen X; Chen J; Yong KT; Yang C; Xu G
Adv Healthc Mater; 2024 Jan; 13(3):e2302409. PubMed ID: 37964681
[TBL] [Abstract][Full Text] [Related]
9. Hollow Inorganic Nanoparticles as Efficient Carriers for siRNA Delivery: A Comprehensive Review.
Varshosaz J; Taymouri S
Curr Pharm Des; 2015; 21(29):4310-28. PubMed ID: 26323421
[TBL] [Abstract][Full Text] [Related]
10. Structure-function relationships of nonviral gene vectors: Lessons from antimicrobial polymers.
Xing H; Lu M; Yang T; Liu H; Sun Y; Zhao X; Xu H; Yang L; Ding P
Acta Biomater; 2019 Mar; 86():15-40. PubMed ID: 30590184
[TBL] [Abstract][Full Text] [Related]
11. Polymeric Nanoparticles in Gene Therapy: New Avenues of Design and Optimization for Delivery Applications.
Rai R; Alwani S; Badea I
Polymers (Basel); 2019 Apr; 11(4):. PubMed ID: 31027272
[TBL] [Abstract][Full Text] [Related]
12. Exosome/Liposome-like Nanoparticles: New Carriers for CRISPR Genome Editing in Plants.
Alghuthaymi MA; Ahmad A; Khan Z; Khan SH; Ahmed FK; Faiz S; Nepovimova E; Kuča K; Abd-Elsalam KA
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299081
[TBL] [Abstract][Full Text] [Related]
13. Non-viral delivery of RNA interference targeting cancer cells in cancer gene therapy.
Huang PI; Lo WL; Cherng JY; Chien Y; Chiou GY; Chiou SH
Curr Gene Ther; 2012 Aug; 12(4):275-84. PubMed ID: 22856602
[TBL] [Abstract][Full Text] [Related]
14. Mesoporous Silica Nanoparticles for Co-Delivery of Drugs and Nucleic Acids in Oncology: A Review.
Paris JL; Vallet-Regí M
Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32521800
[TBL] [Abstract][Full Text] [Related]
15. The research of nanoparticles as gene vector for tumor gene therapy.
Sun NF; Liu ZA; Huang WB; Tian AL; Hu SY
Crit Rev Oncol Hematol; 2014 Mar; 89(3):352-7. PubMed ID: 24210877
[TBL] [Abstract][Full Text] [Related]
16. Clay nanoparticles as pharmaceutical carriers in drug delivery systems.
Dong J; Cheng Z; Tan S; Zhu Q
Expert Opin Drug Deliv; 2021 Jun; 18(6):695-714. PubMed ID: 33301349
[TBL] [Abstract][Full Text] [Related]
17. Aerosol gene delivery using viral vectors and cationic carriers for in vivo lung cancer therapy.
Hong SH; Park SJ; Lee S; Cho CS; Cho MH
Expert Opin Drug Deliv; 2015 Jun; 12(6):977-91. PubMed ID: 25423167
[TBL] [Abstract][Full Text] [Related]
18. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
Li Z; Zhang Y; Feng N
Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
[TBL] [Abstract][Full Text] [Related]
19. Genetically Engineered Viral Vectors and Organic-Based Non-Viral Nanocarriers for Drug Delivery Applications.
Hajebi S; Yousefiasl S; Rahimmanesh I; Dahim A; Ahmadi S; Kadumudi FB; Rahgozar N; Amani S; Kumar A; Kamrani E; Rabiee M; Borzacchiello A; Wang X; Rabiee N; Dolatshahi-Pirouz A; Makvandi P
Adv Healthc Mater; 2022 Oct; 11(20):e2201583. PubMed ID: 35916145
[TBL] [Abstract][Full Text] [Related]
20. Rod-shaped mesoporous silica nanoparticles for nanomedicine: recent progress and perspectives.
Cong VT; Gaus K; Tilley RD; Gooding JJ
Expert Opin Drug Deliv; 2018 Sep; 15(9):881-892. PubMed ID: 30173560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
